Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 16.62M | 16.72M | 17.41M | 17.04M | 18.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.62M | 16.72M | 17.41M | 17.04M | 18.07M |
| Cost of Revenue | 10.37M | 10.49M | 10.04M | 10.24M | 10.36M |
| Gross Profit | 6.25M | 6.23M | 7.37M | 6.80M | 7.71M |
| SG&A Expenses | 18.37M | 17.99M | 18.57M | 17.47M | 16.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.27M | 30.21M | 30.50M | 29.51M | 28.71M |
| Operating Income | -13.65M | -13.49M | -13.09M | -12.47M | -10.64M |
| Income Before Tax | -14.21M | -13.70M | -13.47M | -12.54M | -10.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.21 | -13.70 | -13.47 | -12.54 | -10.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.21M | -13.70M | -13.47M | -12.54M | -10.70M |
| EBIT | -13.65M | -13.49M | -13.09M | -12.47M | -10.64M |
| EBITDA | -12.84M | -12.66M | -12.28M | -11.70M | -9.94M |
| EPS Basic | -0.37 | -0.35 | -0.35 | -0.34 | -0.30 |
| Normalized Basic EPS | -0.24 | -0.23 | -0.22 | -0.21 | -0.19 |
| EPS Diluted | -0.37 | -0.35 | -0.35 | -0.34 | -0.30 |
| Normalized Diluted EPS | -0.24 | -0.23 | -0.22 | -0.21 | -0.19 |
| Average Basic Shares Outstanding | 155.05M | 154.97M | 152.22M | 146.63M | 140.69M |
| Average Diluted Shares Outstanding | 155.05M | 154.97M | 152.22M | 146.63M | 140.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |